Trial registration number
|
CTRI/2022/01/039549 |
Full text link
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=64898
|
First author
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Jananee Muralidharan
|
Contact
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
jananee.m@stjohns.in
|
Registration date
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
2022-01-19
|
Recruitment status
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Not recruiting
|
Study design
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
RCT
|
Allocation
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Randomized
|
Design
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Parallel
|
Masking
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Blind label
|
Center
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
single-center
|
Study aim
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Ageâ?¥18 years nonpregnant patients diagnosed as COVID positive (RAT or RTPCR positive) <br/ >
Oxygen saturation while breathing on ambient room air less than 93% or on already on supplemental oxygen as determined by pulse oximetry measurement or clinically <br/ >
Less than 15 days from symptom onset for COVID-19 <br/ >
Willing to take arginine/placebo as the intervention for ten days and will provide written informed consent <br/ >
|
Exclusion criteria
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Refusal to give consent <br/ >
Unable to take intervention orally for ten days <br/ >
CKD patients on hemodialysis or requiring fluid restriction as part of their management <br/ >
Patient on inotropic support at admission <br/ >
Patients requiring BIPAP (NIV) for an indication other than COVID-19 infection prior to admission <br/ >
Patients will be excluded if progression of the illness to death was imminent and inevitable within 24 hours, as determined by the treating physician. <br/ >
|
Number of arms
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
2
|
Funding
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Clinical Research Centre Dept of Physiology
|
Inclusion age min
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
18
|
Inclusion age max
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
99
|
Countries
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
India
|
Type of patients
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Moderate disease at enrollment
|
Severity scale
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
3: Moderate disease at enrollment
|
Total sample size
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
202
|
primary outcome
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Change in ordinal score in patients on arginine versus placebo. <br/ >Proposed Ordinal Score: <br/ >Category Clinical status Notes <br/ >1 Discharged/Ready for discharge with no symptoms; stable oxygen saturation on ambient air <br/ >2 Ready for discharge with no symptoms; stable oxygen saturation on nasal prongs 2L of oxygen <br/ >3 Hospitalised; on supplemental oxygen via Nasal prongs or Face mask <br/ >4 Hospitalised; on supplemental oxygen via Non rebreathing mask <br/ >5 Hospitalised; on NIV or HFNC <br/ >6 On mechanical ventilation <br/ >7 On mechanical ventilation and inotropes/HD <br/ >8 Dead <br/ > <br/ >Timepoint: Daily assessment over 10 days <br/ >
|
Notes
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
| Declared number of arm (2.0)
differs from found arms (3.0)
|
Phase
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
Not reported
|
Arms
Last imported at : Feb. 25, 2022, noon
Source : International Clinical Trials Registry Platform (ICTRP)
|
[{"arm_notes": "", "treatment_id": 714, "treatment_name": "L-arginine", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|